141 related articles for article (PubMed ID: 11480221)
21. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
Bishnoi M; Chopra K; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
[TBL] [Abstract][Full Text] [Related]
22. Clozapine in tardive dyskinesia: observations from human and animal model studies.
Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
[TBL] [Abstract][Full Text] [Related]
23. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
[TBL] [Abstract][Full Text] [Related]
24. Animal models of tardive dyskinesia--a review.
Kulkarni SK; Naidu PS
Indian J Physiol Pharmacol; 2001 Apr; 45(2):148-60. PubMed ID: 11480221
[TBL] [Abstract][Full Text] [Related]
25. Tardive dyskinesia: pathophysiology and animal models.
Casey DE
J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
[TBL] [Abstract][Full Text] [Related]
26. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?
Jeste DV; Wyatt RJ
J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358
[TBL] [Abstract][Full Text] [Related]
27. Animal models of tardive dyskinesia.
Kulkarni SK; Dhir A
Int Rev Neurobiol; 2011; 98():265-87. PubMed ID: 21907091
[TBL] [Abstract][Full Text] [Related]
28. [Neuroleptic-induced movement disorders: historical perspectives].
Wolf MA; Yassa R; Llorca PM
Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
[TBL] [Abstract][Full Text] [Related]
29. Neuroleptic-induced tardive dyskinesia.
Jenner P; Marsden CD
Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
[TBL] [Abstract][Full Text] [Related]
30. [Physiopathology and curative treatment of tardive dyskinesia].
Wolf MA; Gautier J
Encephale; 1987; 13(5):301-8. PubMed ID: 2892663
[TBL] [Abstract][Full Text] [Related]
31. [Tardive dyskinesia].
Sabbatini F; Gentile S; De Mattei M; Pinessi L; Rainero I
Minerva Med; 1985 Apr; 76(16):797-802. PubMed ID: 2860619
[TBL] [Abstract][Full Text] [Related]
32. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
Barnes TR
Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467
[TBL] [Abstract][Full Text] [Related]
33. [Neuroleptic-induced tardive dyskinesia: recent pathophysiological data, therapeutic trials (author's transl)].
Gaillard-Sizaret C; Gaillard P
Therapie; 1979; 34(5):555-74. PubMed ID: 44767
[No Abstract] [Full Text] [Related]
34. Neurobiochemical changes in tardive dyskinesia.
Gunne LM; Häggström JE; Johansson P; Levin ED; Terenius L
Encephale; 1988 Sep; 14 Spec No():167-73. PubMed ID: 2463901
[TBL] [Abstract][Full Text] [Related]
35. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
Arushanian EB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951
[No Abstract] [Full Text] [Related]
36. Current psychopathological theories of tardive dyskinesia and their implications for future research.
Ananth J
Neuropsychobiology; 1982; 8(4):210-22. PubMed ID: 6127649
[TBL] [Abstract][Full Text] [Related]
37. [Tardive dyskinesia: problems of pathogenesis, treatment and prevention].
Olajossy M
Psychiatr Pol; 1980; 14(6):621-5. PubMed ID: 6112766
[No Abstract] [Full Text] [Related]
38. The current status of tardive dyskinesia.
Sachdev PS
Aust N Z J Psychiatry; 2000 Jun; 34(3):355-69. PubMed ID: 10881961
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
